These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12504717

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy.
    Wang LK, Kansal S, Pulido JS.
    Am J Ophthalmol; 2002 Nov; 134(5):790-2. PubMed ID: 12429271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy increases the eligibility for feeder vessel treatment of choroidal neovascularization caused by age-related macular degeneration.
    Piermarocchi S, Lo Giudice G, Sartore M, Friede F, Segato T, Pilotto E, Midena E.
    Am J Ophthalmol; 2002 Apr; 133(4):572-5. PubMed ID: 11931801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Photodynamic therapy for choroidal neovascularization secondary to choroidal nevus.
    Stanescu D, Wattenberg S, Cohen SY.
    Am J Ophthalmol; 2003 Sep; 136(3):575-6. PubMed ID: 12967828
    [Abstract] [Full Text] [Related]

  • 12. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Successful photodynamic therapy with verteporfin for recurrent choroidal neovascularization beneath the new fovea after macular translocation surgery with 360-degree retinotomy.
    Sawa M, Chan WM, Ohji M, Imai K, Fujikado T, Tano Y, Schachat AP.
    Am J Ophthalmol; 2003 Sep; 136(3):560-3. PubMed ID: 12967821
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [Abstract] [Full Text] [Related]

  • 19. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
    Arevalo JF, Ruiz-Moreno JM, Fernandez CF, Mendoza AJ, Ramirez E, Montero JA.
    Ophthalmic Surg Lasers Imaging; 2004 Oct; 35(1):58-62. PubMed ID: 14750766
    [Abstract] [Full Text] [Related]

  • 20. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
    Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I.
    Am J Ophthalmol; 2001 Apr; 131(4):518-20. PubMed ID: 11292425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.